Cited by 36

Astrocytic microRNAs and transcription factors in Alzheimer’s disease and therapeutic interventions

Nassar, Ajmal, Kodi, Triveni, Satarker, Sairaj, Chowdari Gurram, Prasada, Upadhya, Dinesh, SM, Fayaz, Mudgal, Jayesh, Nampoothiri, Madhavan·2022·Cells

Abstract

Astrocytes are important for maintaining cholesterol metabolism, glutamate uptake, and neurotransmission. Indeed, inflammatory processes and neurodegeneration contribute to the altered morphology, gene expression, and function of astrocytes. Astrocytes, in collaboration with numerous microRNAs, regulate brain cholesterol levels as well as glutamatergic and inflammatory signaling, all of which contribute to general brain homeostasis. Neural electrical activity, synaptic plasticity processes, learning, and memory are dependent on the astrocyte–neuron crosstalk. Here, we review the involvement of astrocytic microRNAs that potentially regulate cholesterol metabolism, glutamate uptake, and inflammation in Alzheimer’s disease (AD). The interaction between astrocytic microRNAs and long non-coding RNA and transcription factors specific to astrocytes also contributes to the pathogenesis of AD. Thus, astrocytic microRNAs arise as a promising target, as AD conditions are a worldwide public health problem. This review examines novel therapeutic strategies to target astrocyte dysfunction in AD, such as lipid nanodiscs, engineered G protein-coupled receptors, extracellular vesicles, and nanoparticles.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11244111

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In AD, a subset of astrocytes undergoes reactive transformation, adopting inflammatory and metabolically altered states that compromise synaptic support and promote neurotoxicity.

    “In AD, however, a subset of astrocytes undergoes reactive transformation, adopting inflammatory and metabolically altered states that compromise synaptic support and promote neurotoxicity (Heneka et al., 2015; Nassar et al., 2022).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 182

  1. [1]Kieran N.W. Suresh R. Dorion M.-F. MacDonald A. Blain M. Wen D. Fuh S.-C. Ryan F. Diaz R.J. Stratton J.A. MicroRNA-210 Regulates the Metabolic and Inflammatory Status of Primary Human Astrocytes J. Neuroinflamm. 2022 19 10 10.1186/s12974-021-02373-y PMC8740343 34991629 · DOI
  2. [2]Ouyang Y.-B. Xu L. Lu Y. Sun X. Yue S. Xiong X.-X. Giffard R.G. Astrocyte-Enriched MiR-29a Targets PUMA and Reduces Neuronal Vulnerability to Forebrain Ischemia Glia 2013 61 1784 1794 10.1002/glia.22556 24038396 PMC3810393 · DOI · Paper page
  3. [3]Bai Y. Su X. Piao L. Jin Z. Jin R. Involvement of Astrocytes and MicroRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential Front. Mol. Neurosci. 2021 14 556215 10.3389/fnmol.2021.556215 33815055 PMC8010124 · DOI
  4. [4]An F. Gong G. Wang Y. Bian M. Yu L. Wei C. MiR-124 Acts as a Target for Alzheimer’s Disease by Regulating BACE1 Oncotarget 2017 8 114065 114071 10.18632/oncotarget.23119 29371969 PMC5768386 · DOI
  5. [5]Salta E. Sierksma A. Vanden Eynden E. De Strooper B. MiR-132 Loss De-represses ITPKB and Aggravates Amyloid and TAU Pathology in Alzheimer’s Brain EMBO Mol. Med. 2016 8 1005 1018 10.15252/emmm.201606520 27485122 PMC5009807 · DOI · Paper page
  6. [6]Xie H. Zhao Y. Zhou Y. Liu L. Liu Y. Wang D. Zhang S. Yang M. MiR-9 Regulates the Expression of BACE1 in Dementia Induced by Chronic Brain Hypoperfusion in Rats Cell. Physiol. Biochem. 2017 42 1213 1226 10.1159/000478919 28683457 · DOI · Paper page
  7. [7]Wang R. Lahiri D.K. Effects of MicroRNA-298 on APP and BACE1 Translation Differ According to Cell Type and 3′-UTR Variation Sci. Rep. 2022 12 3074 10.1038/s41598-022-05164-4 35197498 PMC8866491 · DOI
  8. [10]Raihan O. Brishti A. Molla M.R. Li W. Zhang Q. Xu P. Khan M.I. Zhang J. Liu Q. The Age-Dependent Elevation of MiR-335-3p Leads to Reduced Cholesterol and Impaired Memory in Brain Neuroscience 2018 390 160 173 10.1016/j.neuroscience.2018.08.003 30125687 · DOI
  9. [11]Hauser P.S. Narayanaswami V. Ryan R.O. Apolipoprotein E: From Lipid Transport to Neurobiology Prog. Lipid Res. 2011 50 62 74 10.1016/j.plipres.2010.09.001 20854843 PMC3022415 · DOI · Paper page
  10. [12]Prasad H. Rao R. Amyloid Clearance Defect in ApoE4 Astrocytes Is Reversed by Epigenetic Correction of Endosomal PH Proc. Natl. Acad. Sci. 2018 115 E6640 E6649 10.1073/pnas.1801612115 29946028 PMC6048470 · DOI
  11. [13]Mauch D.H. Nägler K. Schumacher S. Göritz C. Müller E.-C. Otto A. Pfrieger F.W. CNS Synaptogenesis Promoted by Glia-Derived Cholesterol Science (80-.) 2001 294 1354 1357 10.1126/science.294.5545.1354 11701931 · DOI · Paper page
  12. [14]van Deijk A.-L.F. Broersen L.M. Verkuyl J.M. Smit A.B. Verheijen M.H.G. High Content Analysis of Hippocampal Neuron-Astrocyte Co-Cultures Shows a Positive Effect of Fortasyn Connect on Neuronal Survival and Postsynaptic Maturation Front. Neurosci. 2017 11 440 10.3389/fnins.2017.00440 28824363 PMC5543085 · DOI
  13. [15]van Deijk A.-L.F. Camargo N. Timmerman J. Heistek T. Brouwers J.F. Mogavero F. Mansvelder H.D. Smit A.B. Verheijen M.H.G. Astrocyte Lipid Metabolism Is Critical for Synapse Development and Function in Vivo Glia 2017 65 670 682 10.1002/glia.23120 28168742 · DOI · Paper page
  14. [16]Mitsis T. Efthimiadou A. Bacopoulou F. Vlachakis D. Chrousos G.P. Eliopoulos E. Transcription Factors and Evolution: An Integral Part of Gene Expression (Review) World Acad. Sci. J. 2020 2 3 8 10.3892/wasj.2020.32 · DOI
  15. [17]Santos-Terra J. Deckmann I. Fontes-Dutra M. Schwingel G.B. Bambini-Junior V. Gottfried C. Transcription Factors in Neurodevelopmental and Associated Psychiatric Disorders: A Potential Convergence for Genetic and Environmental Risk Factors Int. J. Dev. Neurosci. 2021 81 545 578 10.1002/jdn.10141 34240460 · DOI
  16. [18]Li P. Spolski R. Liao W. Leonard W.J. Complex Interactions of Transcription Factors in Mediating Cytokine Biology in T Cells Immunol. Rev. 2014 261 141 156 10.1111/imr.12199 25123282 PMC4174316 · DOI
  17. [19]Cahoy J.D. Emery B. Kaushal A. Foo L.C. Zamanian J.L. Christopherson K.S. Xing Y. Lubischer J.L. Krieg P.A. Krupenko S.A. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function J. Neurosci. 2008 28 264 278 10.1523/JNEUROSCI.4178-07.2008 18171944 PMC6671143 · DOI · Paper page
  18. [20]Pajarillo E. Rizor A. Lee J. Aschner M. Lee E. The Role of Astrocytic Glutamate Transporters GLT-1 and GLAST in Neurological Disorders: Potential Targets for Neurotherapeutics Neuropharmacology 2019 161 107559 10.1016/j.neuropharm.2019.03.002 30851309 PMC6731169 · DOI
  19. [21]Leng F. Edison P. Neuroinflammation and Microglial Activation in Alzheimer Disease: Where Do We Go from Here? Nat. Rev. Neurol. 2021 17 157 172 10.1038/s41582-020-00435-y 33318676 · DOI · Paper page
  20. [22]Colombo E. Farina C. Astrocytes: Key Regulators of Neuroinflammation Trends Immunol. 2016 37 608 620 10.1016/j.it.2016.06.006 27443914 · DOI
  21. [23]Pekny M. Pekna M. Messing A. Steinhäuser C. Lee J.-M. Parpura V. Hol E.M. Sofroniew M.V. Verkhratsky A. Astrocytes: A Central Element in Neurological Diseases Acta Neuropathol. 2016 131 323 345 10.1007/s00401-015-1513-1 26671410 · DOI
  22. [24]Holtzman D.M. Herz J. Bu G. Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease Cold Spring Harb. Perspect. Med. 2012 2 10.1101/cshperspect.a006312 22393530 PMC3282491 · DOI · Paper page
  23. [25]Avila-Muñoz E. Arias C. Cholesterol-Induced Astrocyte Activation Is Associated with Increased Amyloid Precursor Protein Expression and Processing Glia 2015 63 2010 2022 10.1002/glia.22874 26096015 · DOI
  24. [26]Wang H. Kulas J.A. Wang C. Holtzman D.M. Ferris H.A. Hansen S.B. Regulation of Beta-Amyloid Production in Neurons by Astrocyte-Derived Cholesterol Proc. Natl. Acad. Sci. 2021 118 e2102191118 10.1073/pnas.2102191118 34385305 PMC8379952 · DOI
  25. [27]Zhang J. Liu Q. Cholesterol Metabolism and Homeostasis in the Brain Protein Cell 2015 6 254 264 10.1007/s13238-014-0131-3 25682154 PMC4383754 · DOI · Paper page
  26. [29]Qian L. Chai A.B. Gelissen I.C. Brown A.J. Balancing Cholesterol in the Brain: From Synthesis to Disposal Explor. Neuroprotective Ther. 2022 2 1 27 10.37349/ent.2022.00015 · DOI
  27. [30]Mao S. Sun Q. Xiao H. Zhang C. Li L. Secreted MiR-34a in Astrocytic Shedding Vesicles Enhanced the Vulnerability of Dopaminergic Neurons to Neurotoxins by Targeting Bcl-2 Protein Cell 2015 6 529 540 10.1007/s13238-015-0168-y 26091620 PMC4491052 · DOI · Paper page
  28. [32]Zhan F. Yang J. Lin S. Chen L. MiRNA-Based Signature to Predict the Development of Alzheimer’s Disease Comb. Chem. High Throughput Screen. 2022 25 2103 2111 10.2174/1386207325666220208122911 35139786 · DOI
  29. [33]Berghoff S.A. Spieth L. Sun T. Hosang L. Depp C. Sasmita A.O. Vasileva M.H. Scholz P. Zhao Y. Krueger-Burg D. Neuronal Cholesterol Synthesis Is Essential for Repair of Chronically Demyelinated Lesions in Mice Cell Rep. 2021 37 109889 10.1016/j.celrep.2021.109889 34706227 · DOI
  30. [34]Ikonen E. Cellular Cholesterol Trafficking and Compartmentalization Nat. Rev. Mol. Cell Biol. 2008 9 125 138 10.1038/nrm2336 18216769 · DOI
  31. [35]Fagan A.M. Holtzman D.M. Astrocyte Lipoproteins, Effects of ApoE on Neuronal Function, and Role of ApoE in Amyloid-? Deposition in Vivo Microsc. Res. Tech. 2000 50 297 304 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO;2-C 10936884 · DOI
  32. [36]Savini M. Folick A. Lee Y.-T. Jin F. Cuevas A. Tillman M.C. Duffy J.D. Zhao Q. Neve I.A. Hu P.-W. Lysosome Lipid Signalling from the Periphery to Neurons Regulates Longevity Nat. Cell Biol. 2022 24 906 916 10.1038/s41556-022-00926-8 35681008 PMC9203275 · DOI
  33. [37]Thelen A.M. Zoncu R. Emerging Roles for the Lysosome in Lipid Metabolism Trends Cell Biol. 2017 27 833 850 10.1016/j.tcb.2017.07.006 28838620 PMC5653458 · DOI
  34. [38]Cao J. Huang M. Guo L. Zhu L. Hou J. Zhang L. Pero A. Ng S. El Gaamouch F. Elder G. MicroRNA-195 Rescues ApoE4-Induced Cognitive Deficits and Lysosomal Defects in Alzheimer’s Disease Pathogenesis Mol. Psychiatry 2021 26 4687 4701 10.1038/s41380-020-0824-3 32632205 PMC7785685 · DOI
  35. [39]Suh B.C. Hille B. Regulation of Ion Channels by Phosphatidylinositol 4,5-Bisphosphate Curr. Opin. Neurobiol. 2005 15 370 378 10.1016/j.conb.2005.05.005 15922587 · DOI
  36. [40]Di Paolo G. De Camilli P. Phosphoinositides in Cell Regulation and Membrane Dynamics Nature 2006 443 651 657 10.1038/nature05185 17035995 · DOI · Paper page
  37. [41]Zhu L. Zhong M. Elder G.A. Sano M. Holtzman D.M. Gandy S. Cardozo C. Haroutunian V. Robakis N.K. Cai D. Phospholipid Dysregulation Contributes to Apoe4-Associated Cognitive Deficits in Alzheimer’s Disease Pathogenesis Proc. Natl. Acad. Sci. USA 2015 112 11965 11970 10.1073/pnas.1510011112 26372964 PMC4586834 · DOI · Paper page
  38. [42]Cossec J.C. Lavaur J. Berman D.E. Rivals I. Hoischen A. Stora S. Ripoll C. Mircher C. Grattau Y. Olivomarin J.C. Trisomy for Synaptojanin1 in down Syndrome Is Functionally Linked to the Enlargement of Early Endosomes Hum. Mol. Genet. 2012 21 3156 3172 10.1093/hmg/dds142 22511594 PMC3384382 · DOI
  39. [43]Zhu L. Zhong M. Zhao J. Rhee H. Caesar I. Knight E.M. Volpicelli-Daley L. Bustos V. Netzer W. Liu L. Reduction of Synaptojanin 1 Accelerates Aβ Clearance and Attenuates Cognitive Deterioration in an Alzheimer Mouse Model J. Biol. Chem. 2013 288 32050 32063 10.1074/jbc.M113.504365 24052255 PMC3814799 · DOI · Paper page
  40. [44]Chun Y.S. Shin S. Kim Y. Cho H. Park M.K. Kim T.W. Voronov S.V. Di Paolo G. Suh B.C. Chung S. Cholesterol Modulates Ion Channels via Down-Regulation of Phosphatidylinositol 4,5-Bisphosphate J. Neurochem. 2010 112 1286 1294 10.1111/j.1471-4159.2009.06545.x 20015154 PMC2891522 · DOI
  41. [45]Satarker S. Bojja S.L. Gurram P.C. Mudgal J. Arora D. Nampoothiri M. Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders Cells 2022 11 1139 10.3390/cells11071139 35406702 PMC8997779 · DOI
  42. [46]Rothstein J.D. Martin L. Levey A.I. Dykes-Hoberg M. Jin L. Wu D. Nash N. Kuncl R.W. Localization of Neuronal and Glial Glutamate Transporters Neuron 1994 13 713 725 10.1016/0896-6273(94)90038-8 7917301 · DOI
  43. [47]Marttinen M. Takalo M. Natunen T. Wittrahm R. Gabbouj S. Kemppainen S. Leinonen V. Tanila H. Haapasalo A. Hiltunen M. Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease Front. Neurosci. 2018 12 963 10.3389/fnins.2018.00963 30618585 PMC6301995 · DOI
  44. [48]Mookherjee P. Green P.S. Watson G.S. Marques M.A. Tanaka K. Meeker K.D. Meabon J.S. Li N. Zhu P. Olson V.G. GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer’s Disease Animal Model J. Alzheimer’s Dis. 2011 26 447 455 10.3233/JAD-2011-110503 21677376 PMC3256092 · DOI
  45. [49]Ambros V. Bartel B. Bartel D.P. Burge C.B. Carrington J.C. Chen X. Dreyfuss G. Eddy S.R. Griffiths-Jones S. Marshall M. A Uniform System for MicroRNA Annotation RNA 2003 9 277 279 10.1261/rna.2183803 12592000 PMC1370393 · DOI
  46. [50]Dostie J. Mourelatos Z. Yang M. Sharma A. Dreyfuss G. Numerous MicroRNPs in Neuronal Cells Containing Novel MicroRNAs RNA 2003 9 180 186 10.1261/rna.2141503 12554860 PMC1370383 · DOI · Paper page
  47. [51]Kasashima K. Nakamura Y. Kozu T. Altered Expression Profiles of MicroRNAs during TPA-Induced Differentiation of HL-60 Cells Biochem. Biophys. Res. Commun. 2004 322 403 410 10.1016/j.bbrc.2004.07.130 15325244 · DOI
  48. [53]Lagos-Quintana M. Rauhut R. Yalcin A. Meyer J. Lendeckel W. Tuschl T. Identification of Tissue-Specific MicroRNAs from Mouse Curr. Biol. 2002 12 735 739 10.1016/S0960-9822(02)00809-6 12007417 · DOI · Paper page
  49. [55]Jiang D. Gong F. Ge X. Lv C. Huang C. Feng S. Zhou Z. Rong Y. Wang J. Ji C. Neuron-Derived Exosomes-Transmitted MiR-124-3p Protect Traumatically Injured Spinal Cord by Suppressing the Activation of Neurotoxic Microglia and Astrocytes J. Nanobiotechnolo. 2020 18 105 10.1186/s12951-020-00665-8 PMC7382861 32711535 · DOI · Paper page
  50. [56]Zumkehr J. Rodriguez-Ortiz C.J. Cheng D. Kieu Z. Wai T. Hawkins C. Kilian J. Lim S.L. Medeiros R. Kitazawa M. Ceftriaxone Ameliorates Tau Pathology and Cognitive Decline via Restoration of Glial Glutamate Transporter in a Mouse Model of Alzheimer’s Disease Neurobiol. Aging 2015 36 2260 2271 10.1016/j.neurobiolaging.2015.04.005 25964214 · DOI
  51. [57]Abdul H.M. Sama M.A. Furman J.L. Mathis D.M. Beckett T.L. Weidner A.M. Patel E.S. Baig I. Murphy M.P. LeVine H. Cognitive Decline in Alzheimer’s Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling J. Neurosci. 2009 29 12957 12969 10.1523/JNEUROSCI.1064-09.2009 19828810 PMC2782445 · DOI
  52. [59]Park K. Lee S.J. Deciphering the Star Codings: Astrocyte Manipulation Alters Mouse Behavior Exp. Mol. Med. 2020 52 1028 1038 10.1038/s12276-020-0468-z 32665584 PMC8080576 · DOI
  53. [60]Men Y. Yelick J. Jin S. Tian Y. Chiang M.S.R. Higashimori H. Brown E. Jarvis R. Yang Y. Exosome Reporter Mice Reveal the Involvement of Exosomes in Mediating Neuron to Astroglia Communication in the CNS Nat. Commun. 2019 10 4136 10.1038/s41467-019-11534-w 31515491 PMC6742670 · DOI · Paper page
  54. [61]Morel L. Regan M. Higashimori H. Ng S.K. Esau C. Vidensky S. Rothstein J. Yang Y. Neuronal Exosomal Mirna-Dependent Translational Regulation of Astroglial Glutamate Transporter Glt1 J. Biol. Chem. 2013 288 7105 7116 10.1074/jbc.M112.410944 23364798 PMC3591620 · DOI · Paper page
  55. [62]Peng D. Wang Y. Xiao Y. Peng M. Mai W. Hu B. Jia Y. Chen H. Yang Y. Xiang Q. Extracellular Vesicles Derived from Astrocyte-Treated with HaFGF 14-154 Attenuate Alzheimer Phenotype in AD Mice Theranostics 2022 12 3862 3881 10.7150/thno.70951 35664060 PMC9131260 · DOI
  56. [64]Murphy M.P. LeVine H. Alzheimer’s Disease and the Amyloid-β Peptide J. Alzheimer’s Dis. 2010 19 311 323 10.3233/JAD-2010-1221 20061647 PMC2813509 · DOI · Paper page
  57. [65]Abuelezz N.Z. Nasr F.E. AbdulKader M.A. Bassiouny A.R. Zaky A. MicroRNAs as Potential Orchestrators of Alzheimer’s Disease-Related Pathologies: Insights on Current Status and Future Possibilities Front. Aging Neurosci. 2021 13 743573 10.3389/fnagi.2021.743573 34712129 PMC8546247 · DOI
  58. [66]Lukiw W.J. MicroRNA-146a Signaling in Alzheimer’s Disease (AD) and Prion Disease (PrD) Front. Neurol. 2020 11 462 10.3389/fneur.2020.00462 32670176 PMC7331828 · DOI
  59. [67]Chithanathan K. Somelar K. Jürgenson M. Žarkovskaja T. Periyasamy K. Yan L. Magilnick N. Boldin M.P. Rebane A. Tian L. Enhanced Cognition and Neurogenesis in MiR-146b Deficient Mice Cells 2022 11 2002 10.3390/cells11132002 35805086 PMC9265316 · DOI
  60. [68]Liu D. Zhao D. Zhao Y.Y. Wang Y. Zhao Y.Y. Wen C. Inhibition of MicroRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of Neuroinflammation Curr. Alzheimer Res. 2019 16 473 482 10.2174/1567205016666190503145207 31456514 · DOI
  61. [69]Mor E. Cabilly Y. Goldshmit Y. Zalts H. Modai S. Edry L. Elroy-Stein O. Shomron N. Species-Specific MicroRNA Roles Elucidated Following Astrocyte Activation Nucleic Acids Res. 2011 39 3710 3723 10.1093/nar/gkq1325 21247879 PMC3089466 · DOI
  62. [70]Gasiorowska A. Wydrych M. Drapich P. Zadrozny M. Steczkowska M. Niewiadomski W. Niewiadomska G. The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain Front. Aging Neurosci. 2021 13 654931 10.3389/fnagi.2021.654931 34326765 PMC8315271 · DOI
  63. [71]Li M. Long C. Yang L. Hippocampal-Prefrontal Circuit and Disrupted Functional Connectivity in Psychiatric and Neurodegenerative Disorders Biomed Res. Int. 2015 2015 1 10 10.1155/2015/810548 25918722 PMC4396015 · DOI
  64. [72]Xing B. Li Y.-C. Gao W.-J. Norepinephrine versus Dopamine and Their Interaction in Modulating Synaptic Function in the Prefrontal Cortex Brain Res. 2016 1641 217 233 10.1016/j.brainres.2016.01.005 26790349 PMC4879059 · DOI · Paper page
  65. [73]Zingale V.D. Gugliandolo A. Mazzon E. MiR-155: An Important Regulator of Neuroinflammation Int. J. Mol. Sci. 2021 23 90 10.3390/ijms23010090 35008513 PMC8745074 · DOI · Paper page
  66. [74]Perez-Nievas B.G. Serrano-Pozo A. Deciphering the Astrocyte Reaction in Alzheimer’s Disease Front. Aging Neurosci. 2018 10 114 10.3389/fnagi.2018.00114 29922147 PMC5996928 · DOI · Paper page
  67. [75]Li Y. Li L. Wu J. Zhu Z. Feng X. Qin L. Zhu Y. Sun L. Liu Y. Qiu Z. Activation of Astrocytes in Hippocampus Decreases Fear Memory through Adenosine A1 Receptors Elife 2020 9 e57155 10.7554/eLife.57155 32869747 PMC7505657 · DOI
  68. [76]Walker D.G. Whetzel A.M. Lue L.-F. Expression of Suppressor of Cytokine Signaling Genes in Human Elderly and Alzheimer’s Disease Brains and Human Microglia Neuroscience 2015 302 121 137 10.1016/j.neuroscience.2014.09.052 25286386 PMC4385752 · DOI
  69. [77]Mudgal J. Basu Mallik S. Nampoothiri M. Kinra M. Hall S. Grant G.D. Anoopkumar-Dukie S. Davey A.K. Rao C.M. Arora D. Effect of Coffee Constituents, Caffeine and Caffeic Acid on Anxiety and Lipopolysaccharide-Induced Sickness Behavior in Mice J. Funct. Foods 2020 64 103638 10.1016/j.jff.2019.103638 · DOI
  70. [78]Fan W. Liang C. Ou M. Zou T. Sun F. Zhou H. Cui L. MicroRNA-146a Is a Wide-Reaching Neuroinflammatory Regulator and Potential Treatment Target in Neurological Diseases Front. Mol. Neurosci. 2020 13 90 10.3389/fnmol.2020.00090 32581706 PMC7291868 · DOI · Paper page
  71. [79]Ma Y. Ye J. Zhao L. Pan D. MicroRNA-146a Inhibition Promotes Total Neurite Outgrowth and Suppresses Cell Apoptosis, Inflammation, and STAT1/MYC Pathway in PC12 and Cortical Neuron Cellular Alzheimer’s Disease Models Brazilian J. Med. Biol. Res. 2021 54 e9665 10.1590/1414-431x20209665 PMC7959174 33729395 · DOI
  72. [80]Gião T. Teixeira T. Almeida M.R. Cardoso I. Choroid Plexus in Alzheimer’s Disease—The Current State of Knowledge Biomedicines 2022 10 224 10.3390/biomedicines10020224 35203434 PMC8869376 · DOI · Paper page
  73. [81]Grapp M. Wrede A. Schweizer M. Hüwel S. Galla H.J. Snaidero N. Simons M. Bückers J. Low P.S. Urlaub H. Choroid Plexus Transcytosis and Exosome Shuttling Deliver Folate into Brain Parenchyma Nat. Commun. 2013 4 2123 10.1038/ncomms3123 23828504 · DOI
  74. [82]Prado Lima M.G. Schimidt H.L. Garcia A. Daré L.R. Carpes F.P. Izquierdo I. Mello-Carpes P.B. Environmental Enrichment and Exercise Are Better than Social Enrichment to Reduce Memory Deficits in Amyloid Beta Neurotoxicity Proc. Natl. Acad. Sci. USA 2018 115 E2403 E2409 10.1073/pnas.1718435115 29463708 PMC5877978 · DOI
  75. [83]Nakano M. Kubota K. Hashizume S. Kobayashi E. Chikenji T.S. Saito Y. Fujimiya M. An Enriched Environment Prevents Cognitive Impairment in an Alzheimer’s Disease Model by Enhancing the Secretion of Exosomal MicroRNA-146a from the Choroid Plexus Brain, Behav. Immun. - Heal. 2020 9 100149 10.1016/j.bbih.2020.100149 34589894 PMC8474441 · DOI
  76. [85]Kinra M. Joseph A. Nampoothiri M. Arora D. Mudgal J. Inhibition of NLRP3-Inflammasome Mediated IL-1β Release by Phenylpropanoic Acid Derivatives: In-Silico and in-Vitro Approach Eur. J. Pharm. Sci. 2021 157 105637 10.1016/j.ejps.2020.105637 33171231 · DOI
  77. [86]Qin C. Li Y. Wang K. Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation J. Inflamm. Res. 2021 14 4761 4775 10.2147/JIR.S327538 34566422 PMC8456430 · DOI
  78. [87]Kubota K. Nakano M. Kobayashi E. Mizue Y. Chikenji T. Otani M. Nagaishi K. Fujimiya M. An Enriched Environment Prevents Diabetes-Induced Cognitive Impairment in Rats by Enhancing Exosomal MiR-146a Secretion from Endogenous Bone Marrow-Derived Mesenchymal Stem Cells PLoS ONE 2018 13 e0204252 10.1371/journal.pone.0204252 30240403 PMC6150479 · DOI
  79. [88]Nakano M. Nagaishi K. Konari N. Saito Y. Chikenji T. Mizue Y. Fujimiya M. Bone Marrow-Derived Mesenchymal Stem Cells Improve Diabetes-Induced Cognitive Impairment by Exosome Transfer into Damaged Neurons and Astrocytes Sci. Rep. 2016 6 24805 10.1038/srep24805 27102354 PMC4840335 · DOI
  80. [89]Fu Y. Zhou Y. Zhang Y.-L. Zhao B. Zhang X.-L. Zhang W.-T. Lu Y.-J. Lu A. Zhang J.J. Zhang J.J. Loss of Neurodevelopmental-Associated MiR-592 Impairs Neurogenesis and Causes Social Interaction Deficits Cell Death Dis. 2022 13 292 10.1038/s41419-022-04721-z 35365601 PMC8976077 · DOI
  81. [91]Uruno A. Motohashi H. The Keap1-Nrf2 System as an in Vivo Sensor for Electrophiles Nitric Oxide - Biol. Chem. 2011 25 153 160 10.1016/j.niox.2011.02.007 21385624 · DOI
  82. [92]Turpaev K.T. Keap1-Nrf2 Signaling Pathway: Mechanisms of Regulation and Role in Protection of Cells against Toxicity Caused by Xenobiotics and Electrophiles Biochem. 2013 78 111 126 10.1134/S0006297913020016 23581983 · DOI
  83. [93]Xian P. Hei Y. Wang R. Wang T. Yang J. Li J. Di Z. Liu Z. Baskys A. Liu W. Mesenchymal Stem Cell-Derived Exosomes as a Nanotherapeutic Agent for Amelioration of Inflammation-Induced Astrocyte Alterations in Mice Theranostics 2019 9 5956 5975 10.7150/thno.33872 31534531 PMC6735367 · DOI
  84. [94]Zhao W. Gasterich N. Clarner T. Voelz C. Behrens V. Beyer C. Fragoulis A. Zendedel A. Astrocytic Nrf2 Expression Protects Spinal Cord from Oxidative Stress Following Spinal Cord Injury in a Male Mouse Model J. Neuroinflamm. 2022 19 134 10.1186/s12974-022-02491-1 35668451 PMC9169394 · DOI
  85. [95]Draheim T. Liessem A. Scheld M. Wilms F. Weißflog M. Denecke B. Kensler T.W. Zendedel A. Beyer C. Kipp M. Activation of the Astrocytic Nrf2/ARE System Ameliorates the Formation of Demyelinating Lesions in a Multiple Sclerosis Animal Model Glia 2016 64 2219 2230 10.1002/glia.23058 27641725 · DOI · Paper page
  86. [96]De Wu G. Li Z.H. Li X. Zheng T. Zhang D.K. MicroRNA-592 Blockade Inhibits Oxidative Stress Injury in Alzheimer’s Disease Astrocytes via the KIAA0319-Mediated Keap1/Nrf2/ARE Signaling Pathway Exp. Neurol. 2020 324 113128 10.1016/j.expneurol.2019.113128 31759899 · DOI
  87. [97]Liu X. Hao L. Li D. Zhu L. Hu S. Long Non-Coding RNAs and Their Biological Roles in Plants Genomics. Proteom. Bioinforma. 2015 13 137 147 10.1016/j.gpb.2015.02.003 PMC4563214 25936895 · DOI
  88. [98]Lyu Y. Bai L. Qin C. Long Noncoding RNAs in Neurodevelopment and Parkinson’s Disease Anim. Model. Exp. Med. 2019 2 239 251 10.1002/ame2.12093 PMC6930994 31942556 · DOI
  89. [99]Abdolmaleki A. Ferdowsi S. Asadi A. Panahi Y. Long Non-Coding RNAs Associated with Brain Disorders: A Literature Review Gene Cell Tissue 2021 8 e111802 10.5812/gct.111802 · DOI
  90. [100]Zheng Q. Lin Z. Xu J. Lu Y. Meng Q. Wang C. Yang Y. Xin X. Li X. Pu H. Long Noncoding RNA MEG3 Suppresses Liver Cancer Cells Growth through Inhibiting β-Catenin by Activating PKM2 and Inactivating PTEN Cell Death Dis. 2018 9 253 10.1038/s41419-018-0305-7 29449541 PMC5833746 · DOI
  91. [101]Meng J. Ding T. Chen Y. Long T. Xu Q. Lian W. Liu W. LncRNA-Meg3 Promotes Nlrp3-Mediated Microglial Inflammation by Targeting MiR-7a-5p Int. Immunopharmacol. 2021 90 107141 10.1016/j.intimp.2020.107141 33189612 · DOI
  92. [102]Kinra M. Nampoothiri M. Arora D. Mudgal J. Reviewing the Importance of TLR-NLRP3-pyroptosis Pathway and Mechanism of Experimental NLRP3 Inflammasome Inhibitors Scand. J. Immunol. 2022 95 e13124 10.1111/sji.13124 34861056 · DOI
  93. [103]Yi J. Chen B. Yao X. Lei Y. Ou F. Huang F. Upregulation of the LncRNA MEG3 Improves Cognitive Impairment, Alleviates Neuronal Damage, and Inhibits Activation of Astrocytes in Hippocampus Tissues in Alzheimer’s Disease through Inactivating the PI3K/Akt Signaling Pathway J. Cell. Biochem. 2019 120 18053 18065 10.1002/jcb.29108 31190362 · DOI
  94. [104]Duan R. Wang S.Y. Wei B. Deng Y. Fu X.X. Gong P.Y. Yan E. Sun X.J. Cao H.M. Shi J.Q. Angiotensin-(1–7) Analogue AVE0991 Modulates Astrocyte-Mediated Neuroinflammation via LncRNA SNHG14/MiR-223-3p/NLRP3 Pathway and Offers Neuroprotection in a Transgenic Mouse Model of Alzheimer’s Disease J. Inflamm. Res. 2021 14 7007 7019 10.2147/JIR.S343575 34955647 PMC8694579 · DOI
  95. [105]Zhang M. He P. Bian Z. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers Front. Mol. Neurosci. 2021 14 685143 10.3389/fnmol.2021.685143 34421536 PMC8371338 · DOI
  96. [106]Jiang X. Wu Q. Zhang C. Wang M. Homoharringtonine Inhibits Alzheimer’s Disease Progression by Reducing Neuroinflammation via STAT3 Signaling in APP/PS1 Mice Neurodegener. Dis. 2022 21 93 102 10.1159/000519974 34808617 · DOI
  97. [107]Wan J. Fu A.K.Y. Ip F.C.F. Ng H. Hugon J. Wang J.H. Lai K. Wu Z. Ip N.Y. Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: Implications in Alzheimer’s disease J. Neurosci. 2010 30 6873 6881 10.1523/JNEUROSCI.0519-10.2010 20484629 PMC6632652 · DOI
  98. [108]Gao P. Wang Z. Lei M. Che J. Zhang S. Zhang T. Hu Y. Shi L. Cui L. Liu J. Daphnetin Ameliorates Aβ Pathogenesis via STAT3/GFAP Signaling in an APP/PS1 Double-Transgenic Mouse Model of Alzheimer’s Disease Pharmacol. Res. 2022 180 106227 10.1016/j.phrs.2022.106227 35452800 · DOI
  99. [109]Ben Haim L. Carrillo-de Sauvage M.A. Ceyzériat K. Escartin C. Elusive Roles for Reactive Astrocytes in Neurodegenerative Diseases Front. Cell. Neurosci. 2015 9 278 10.3389/fncel.2015.00278 26283915 PMC4522610 · DOI · Paper page
  100. [110]Neal M. Richardson J.R. Epigenetic Regulation of Astrocyte Function in Neuroinflammation and Neurodegeneration Biochim. Biophys. Acta - Mol. Basis Dis. 2018 1864 432 443 10.1016/j.bbadis.2017.11.004 29113750 PMC5743548 · DOI
  101. [111]Mishra S. Maurya S.K. Srivastava K. Shukla S. Mishra R. Pax6 Influences Expression Patterns of Genes Involved in Neuro-Degeneration Ann. Neurosci. 2015 22 226 231 10.5214/ans.0972.7531.220407 26525840 PMC4627194 · DOI
  102. [112]Singh M.P. Vamanu E. Therapeutic Potential of Vital Transcription Factors in Alzheimer’s and Parkinson’s Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy Front. Neurosci. 2021 15 777347 10.3389/fnins.2021.777347 34970114 PMC8712758 · DOI
  103. [113]La Spina M. Contreras P.S. Rissone A. Meena N.K. Jeong E. Martina J.A. MiT/TFE Family of Transcription Factors: An Evolutionary Perspective Front. Cell Dev. Biol. 2021 8 1 22 10.3389/fcell.2020.609683 33490073 PMC7815692 · DOI
  104. [114]Aguirre-rueda D. Guerra-ojeda S. Aldasoro M. Iradi A. Obrador E. Ortega A. Mauricio D. Vila J.M. Valles S.L. Astrocytes Protect Neurons from A β 1-42 Peptide- Induced Neurotoxicity Increasing TFAM and PGC-1 and Decreasing PPAR- γ and SIRT-1 Int. J. Med. Sci. 2015 12 48 56 10.7150/ijms.10035 25552918 PMC4278875 · DOI
  105. [115]Li Q. Overseeing Memory Circuits by NFIA: New Face In Astrocytes Neuron 2020 106 878 880 10.1016/j.neuron.2020.05.027 32553203 · DOI
  106. [116]Wang Z.H. Gong K. Liu X. Zhang Z. Sun X. Wei Z.Z. Yu S.P. Manfredsson F.P. Sandoval I.M. Johnson P.F. Author Correction: C/EBPβ Regulates Delta-Secretase Expression and Mediates Pathogenesis in Mouse Models of Alzheimer’s Disease Nat. Commun. 2019 10 41467 10.1038/s41467-019-13553-z PMC6879502 31772180 · DOI
  107. [117]Nowak K. Lange-Dohna C. Zeitschel U. Günther A. Lüscher B. Robitzki A. Perez-Polo R. Roßner S. The Transcription Factor Yin Yang 1 Is an Activator of BACE1 Expression J. Neurochem. 2006 96 1696 1707 10.1111/j.1471-4159.2006.03692.x 16539685 · DOI
  108. [118]Chen Z.S. Chan H.Y.E. Transcriptional Dysregulation in Neurodegenerative Diseases: Who Tipped the Balance of Yin Yang 1 in the Brain? Neural Regen. Res. 2019 14 1148 1151 10.4103/1673-5374.251193 30804239 PMC6425841 · DOI
  109. [119]Wang Y. Jia A. Ma W. Dexmedetomidine Attenuates the Toxicity of β-Amyloid on Neurons and Astrocytes by Increasing BDNF Production under the Regulation of HDAC2 and HDAC5 Mol. Med. Rep. 2019 19 533 540 10.3892/mmr.2018.9694 30483749 · DOI
  110. [120]Sen T. Sen N. Isoflurane-Induced Inactivation of CREB through Histone Deacetylase 4 Is Responsible for Cognitive Impairment in Developing Brain Neurobiol. Dis. 2016 96 12 21 10.1016/j.nbd.2016.08.005 27544482 PMC5102759 · DOI
  111. [121]Jeon S.G. Yoo A. Chun D.W. Hong S.B. Chung H. Kim J.-I. Moon M. The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-Related Pathogenesis Aging Dis. 2020 11 705 724 10.14336/AD.2019.0718 32489714 PMC7220289 · DOI
  112. [122]Yi-Bin W. Xiang L. Bing Y. Qi Z. Fei-Tong J. Minghong W. Xiangxiang Z. Le K. Yan L. Ping S. Inhibition of the CEBPβ-NFκB Interaction by Nanocarrier-Packaged Carnosic Acid Ameliorates Glia-Mediated Neuroinflammation and Improves Cognitive Function in an Alzheimer’s Disease Model Cell Death Dis. 2022 13 1 18 10.1038/s41419-022-04765-1 35393391 PMC8989877 · DOI
  113. [123]123. Delgado-Morales R. Agís-Balboa R.C. Esteller M. Berdasco M. Epigenetic Mechanisms during Ageing and Neurogenesis as Novel Therapeutic Avenues in Human Brain Disorder Clin Epigenetics 2017 29 67 10.1186/s13148-017-0365-z 28670349 PMC5493012 · DOI
  114. [124]Alberini C.M. Kandel E.R. The Regulation of Transcription in Memory Consolidation Cold Spring Harb. Perspect. Biol. 2015 7 a021741 10.1101/cshperspect.a021741 25475090 PMC4292167 · DOI · Paper page
  115. [126]Button E.B. Boyce G.K. Wilkinson A. Stukas S. Hayat A. Fan J. Wadsworth B.J. Robert J. Martens K.M. Wellington C.L. ApoA-I Deficiency Increases Cortical Amyloid Deposition, Cerebral Amyloid Angiopathy, Cortical and Hippocampal Astrogliosis, and Amyloid-Associated Astrocyte Reactivity in APP/PS1 Mice Alzheimers. Res. Ther. 2019 11 44 10.1186/s13195-019-0497-9 31084613 PMC6515644 · DOI
  116. [127]Ito J. Michikawa M. ApoA-I/HDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes J. Lipids 2014 2014 1 9 10.1155/2014/530720 PMC4146353 25197575 · DOI
  117. [128]Shelby M. Gilbile D. Grant T. Bauer W. Segelke B. He W. Evans A. Crespo N. Fischer P. Pakendorf T. Crystallization of ApoA1 and ApoE4 Nanolipoprotein Particles and Initial XFEL-Based Structural Studies Crystals 2020 10 886 10.3390/cryst10100886 35686136 PMC9175823 · DOI
  118. [129]Pourmousa M. Pastor R.W. Molecular Dynamics Simulations of Lipid Nanodiscs Biochim. Biophys. Acta - Biomembr. 2018 1860 2094 2107 10.1016/j.bbamem.2018.04.015 29729280 PMC6218321 · DOI
  119. [130]Rawat V. Wang S. Sima J. Bar R. Liraz O. Gundimeda U. Parekh T. Chan J. Johansson J.O. Tang C. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes J. Neurosci. 2019 39 9611 9622 10.1523/JNEUROSCI.1400-19.2019 31641056 PMC6880458 · DOI · Paper page
  120. [131]Barber C.N. Raben D.M. Lipid Metabolism Crosstalk in the Brain: Glia and Neurons Front. Cell. Neurosci. 2019 13 212 10.3389/fncel.2019.00212 31164804 PMC6536584 · DOI · Paper page
  121. [132]Merched A. Xia Y. Visvikis S. Serot J.M. Siest G. Decreased High-Density Lipoprotein Cholesterol and Serum Apolipoprotein AI Concentrations Are Highly Correlated with the Severity of Alzheimer’s Disease Neurobiol. Aging 2000 21 27 30 10.1016/S0197-4580(99)00103-7 10794845 · DOI
  122. [133]Chen J. Zhang X. Kusumo H. Costa L.G. Guizzetti M. Cholesterol Efflux Is Differentially Regulated in Neurons and Astrocytes: Implications for Brain Cholesterol Homeostasis Biochim. Biophys. Acta - Mol. Cell Biol. Lipids 2013 1831 263 275 10.1016/j.bbalip.2012.09.007 23010475 PMC3534809 · DOI · Paper page
  123. [134]Slot R.E.R. Van Harten A.C. Kester M.I. Jongbloed W. Bouwman F.H. Teunissen C.E. Scheltens P. Veerhuis R. Van Der Flier W.M. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer’s Disease in Non-Demented Elderly J. Alzheimer’s Dis. 2017 56 687 697 10.3233/JAD-151068 28035918 · DOI
  124. [135]Wahrle S.E. Jiang H. Parsadanian M. Legleiter J. Han X. Fryer J.D. Kowalewski T. Holtzman D.M. ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-Secreted ApoE J. Biol. Chem. 2004 279 40987 40993 10.1074/jbc.M407963200 15269217 · DOI · Paper page
  125. [136]Sierri G. Dal Magro R. Vergani B. Leone B.E. Formicola B. Taiarol L. Fagioli S. Kravicz M. Tremolizzo L. Calabresi L. Reduced Levels of ABCA1 Transporter Are Responsible for the Cholesterol Efflux Impairment in Β-amyloid-induced Reactive Astrocytes: Potential Rescue from Biomimetic HDLs Int. J. Mol. Sci. 2022 23 102 10.3390/ijms23010102 PMC8745016 35008528 · DOI
  126. [138]Pandian S.R.K. Vijayakumar K.K. Murugesan S. Kunjiappan S. Liposomes: An Emerging Carrier for Targeting Alzheimer’s and Parkinson’s Diseases Heliyon 2022 8 e09575 10.1016/j.heliyon.2022.e09575 35706935 PMC9189891 · DOI
  127. [139]Suesca E. Alejo J.L. Bolaños N.I. Ocampo J. Leidy C. González J.M. Sulfocerebrosides Upregulate Liposome Uptake in Human Astrocytes without Inducing a Proinflammatory Response Cytom. Part A 2013 83 627 635 10.1002/cyto.a.22305 23671026 · DOI
  128. [140]Kuo Y.C. Tsao C.W. Neuroprotection against Apoptosis of SK-N-MC Cells Using RMP-7- and Lactoferrin-Grafted Liposomes Carrying Quercetin Int. J. Nanomedicine 2017 12 2857 2869 10.2147/IJN.S132472 28435263 PMC5391167 · DOI
  129. [141]Yamamoto S. Kayama T. Noguchi-Shinohara M. Hamaguchi T. Yamada M. Abe K. Kobayashi S. Rosmarinic Acid Suppresses Tau Phosphorylation and Cognitive Decline by Downregulating the JNK Signaling Pathway NPJ Sci. Food 2021 5 1 10.1038/s41538-021-00084-5 33514742 PMC7846760 · DOI
  130. [142]Fachel F.N.S. Dal Prá M. Azambuja J.H. Endres M. Bassani V.L. Koester L.S. Henriques A.T. Barschak A.G. Teixeira H.F. Braganhol E. Glioprotective Effect of Chitosan-Coated Rosmarinic Acid Nanoemulsions Against Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Rat Astrocyte Primary Cultures Cell. Mol. Neurobiol. 2020 40 123 139 10.1007/s10571-019-00727-y 31446560 PMC11449031 · DOI
  131. [143]Fachel F.N.S. Michels L.R. Azambuja J.H. Lenz G.S. Gelsleichter N.E. Endres M. Scholl J.N. Schuh R.S. Barschak A.G. Figueiró F. Chitosan-Coated Rosmarinic Acid Nanoemulsion Nasal Administration Protects against LPS-Induced Memory Deficit, Neuroinflammation, and Oxidative Stress in Wistar Rats Neurochem. Int. 2020 141 104875 10.1016/j.neuint.2020.104875 33039443 · DOI
  132. [144]Urban D.J. Roth B.L. DREADDs (Designer Receptors Exclusively Activated by Designer Drugs): Chemogenetic Tools with Therapeutic Utility Annu. Rev. Pharmacol. Toxicol. 2015 55 399 417 10.1146/annurev-pharmtox-010814-124803 25292433 · DOI
  133. [145]Zhu H. Roth B.L. DREADD: A Chemogenetic GPCR Signaling Platform Int. J. Neuropsychopharmacol. 2015 18 pyu007 10.1093/ijnp/pyu007 25522378 PMC4368861 · DOI
  134. [146]Kamato D. Thach L. Bernard R. Chan V. Zheng W. Kaur H. Brimble M. Osman N. Little P.J. Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11 Front. Cardiovasc. Med. 2015 2 14 10.3389/fcvm.2015.00014 26664886 PMC4671355 · DOI
  135. [147]Jendryka M. Palchaudhuri M. Ursu D. van der Veen B. Liss B. Kätzel D. Nissen W. Pekcec A. Pharmacokinetic and Pharmacodynamic Actions of Clozapine-N-Oxide, Clozapine, and Compound 21 in DREADD-Based Chemogenetics in Mice Sci. Rep. 2019 9 4522 10.1038/s41598-019-41088-2 30872749 PMC6418145 · DOI · Paper page
  136. [148]Xu Y.-X. Wang C. Li X.-D. Guo W.-L. Liu G.-Y. Zhang H.-B. Sun Y. Zhu D.-F. Xu Q. Activation of Cholinergic Basal Forebrain Neurons Improved Cognitive Functions in Adult-Onset Hypothyroid Mice Biomed. Pharmacother. 2022 153 113495 10.1016/j.biopha.2022.113495 36076509 · DOI
  137. [149]Shan Q. Fang Q. Tian Y. Evidence That GIRK Channels Mediate the DREADD-HM4Di Receptor Activation-Induced Reduction in Membrane Excitability of Striatal Medium Spiny Neurons ACS Chem. Neurosci. 2022 13 2084 2091 10.1021/acschemneuro.2c00304 35766981 · DOI · Paper page
  138. [150]Hirbec H. Déglon N. Foo L.C. Goshen I. Grutzendler J. Hangen E. Kreisel T. Linck N. Muffat J. Regio S. Emerging Technologies to Study Glial Cells Glia 2020 68 1692 1728 10.1002/glia.23780 31958188 · DOI
  139. [151]Kim J.H. Rahman M.H. Lee W.H. Suk K. Chemogenetic Stimulation of the Gi Pathway in Astrocytes Suppresses Neuroinflammation Pharmacol. Res. Perspect. 2021 9 e00822 10.1002/prp2.822 34676988 PMC8532135 · DOI
  140. [152]Dusaban S.S. Purcell N.H. Rockenstein E. Masliah E. Cho M.K. Smrcka A.V. Brown J.H. Phospholipase Cε Links G Protein-Coupled Receptor Activation to Inflammatory Astrocytic Responses Proc. Natl. Acad. Sci. USA 2013 110 3609 3614 10.1073/pnas.1217355110 23401561 PMC3587233 · DOI
  141. [153]Nam M.H. Han K.S. Lee J. Won W. Koh W. Bae J.Y. Woo J. Kim J. Kwong E. Choi T.Y. Activation of Astrocytic μ-Opioid Receptor Causes Conditioned Place Preference Cell Rep. 2019 28 1154 1166.e5 10.1016/j.celrep.2019.06.071 31365861 · DOI
  142. [155]Vaidyanathan T.V. Collard M. Yokoyama S. Reitman M.E. Poskanzer K.E. Cortical Astrocytes Independently Regulate Sleep Depth and Duration via Separate GPCR Pathways Elife 2021 10 e63329 10.7554/eLife.63329 33729913 PMC7968927 · DOI
  143. [158]Kofuji P. Araque A. G-Protein-Coupled Receptors in Astrocyte–Neuron Communication Neuroscience 2021 456 71 84 10.1016/j.neuroscience.2020.03.025 32224231 PMC8817509 · DOI
  144. [159]Van Den Herrewegen Y. Sanderson T.M. Sahu S. De Bundel D. Bortolotto Z.A. Smolders I. Side-by-Side Comparison of the Effects of Gq- and Gi-DREADD-Mediated Astrocyte Modulation on Intracellular Calcium Dynamics and Synaptic Plasticity in the Hippocampal CA1 Mol. Brain 2021 14 144 10.1186/s13041-021-00856-w 34544455 PMC8451082 · DOI
  145. [161]Cacciatore I. Ciulla M. Fornasari E. Marinelli L. Di Stefano A. Solid Lipid Nanoparticles as a Drug Delivery System for the Treatment of Neurodegenerative Diseases Expert Opin. Drug Deliv. 2016 13 1121 1131 10.1080/17425247.2016.1178237 27073977 · DOI
  146. [162]Spampinato S.F. Bortolotto V. Canonico P.L. Sortino M.A. Grilli M. Astrocyte-Derived Paracrine Signals: Relevance for Neurogenic Niche Regulation and Blood-Brain Barrier Integrity Front. Pharmacol. 2019 10 1346 10.3389/fphar.2019.01346 31824311 PMC6881379 · DOI
  147. [163]Piantino M. Louis F. Shigemoto-Mogami Y. Kitamura K. Sato K. Yamaguchi T. Kawabata K. Yamamoto S. Iwasaki S. Hirabayashi H. Brain Microvascular Endothelial Cells Derived from Human Induced Pluripotent Stem Cells as in Vitro Model for Assessing Blood-Brain Barrier Transferrin Receptor-Mediated Transcytosis Mater. Today Bio 2022 14 100232 10.1016/j.mtbio.2022.100232 35308041 PMC8927846 · DOI
  148. [164]Manfredsson F.P. Mandel R.J. Development of Gene Therapy for Neurological Disorders Available online: https://pubmed.ncbi.nlm.nih.gov/20350486/ (accessed on 30 October 2022)
  149. [165]Sloane E. Ledeboer A. Seibert W. Coats B. van Strien M. Maier S.F. Johnson K.W. Chavez R. Watkins L.R. Leinwand L. Anti-Inflammatory Cytokine Gene Therapy Decreases Sensory and Motor Dysfunction in Experimental Multiple Sclerosis: MOG-EAE Behavioral and Anatomical Symptom Treatment with Cytokine Gene Therapy Brain. Behav. Immun. 2009 23 92 100 10.1016/j.bbi.2008.09.004 18835435 PMC2631931 · DOI
  150. [166]Deverman B.E. Patterson P.H. Exogenous Leukemia Inhibitory Factor Stimulates Oligodendrocyte Progenitor Cell Proliferation and Enhances Hippocampal Remyelination J. Neurosci. 2012 32 2100 2109 10.1523/JNEUROSCI.3803-11.2012 22323722 PMC3561904 · DOI
  151. [167]Kriaučiūnaitė K. Kaušylė A. Pajarskienė J. Tunaitis V. Lim D. Verkhratsky A. Pivoriūnas A. Immortalised Hippocampal Astrocytes from 3xTG-AD Mice Fail to Support BBB Integrity In Vitro: Role of Extracellular Vesicles in Glial-Endothelial Communication Cell. Mol. Neurobiol. 2021 41 551 562 10.1007/s10571-020-00871-w 32440709 PMC11448679 · DOI
  152. [168]Pan S.M. Zhou Y.F. Zuo N. Jiao R.Q. Kong L.D. Pan Y. Fluoxetine Increases Astrocytic Glucose Uptake and Glycolysis in Corticosterone-Induced Depression through Restricting GR-TXNIP-GLUT1 Pathway Front. Pharmacol. 2022 13 872375 10.3389/fphar.2022.872375 36105196 PMC9465171 · DOI
  153. [169]Ahmed Juvale I.I. Abdul Hamid A.A. Abd Halim K.B. Che Has A.T. P-Glycoprotein: New Insights into Structure, Physiological Function, Regulation and Alterations in Disease Heliyon 2022 8 e09777 10.1016/j.heliyon.2022.e09777 35789865 PMC9249865 · DOI
  154. [171]Ding Y. Zhong Y. Baldeshwiler A. Abner E.L. Bauer B. Hartz A.M.S. Protecting P-Glycoprotein at the Blood–Brain Barrier from Degradation in an Alzheimer’s Disease Mouse Model Fluids Barriers CNS 2021 18 1 10 10.1186/s12987-021-00245-4 33676539 PMC7937299 · DOI
  155. [172]Vecino E. Rodriguez F.D. Ruzafa N. Pereiro X. Sharma S.C. Glia-Neuron Interactions in the Mammalian Retina Prog. Retin. Eye Res. 2016 51 1 40 10.1016/j.preteyeres.2015.06.003 26113209 · DOI
  156. [173]Crivelli S.M. Luo Q. Stevens J.A.A. Giovagnoni C. van Kruining D. Bode G. den Hoedt S. Hobo B. Scheithauer A.L. Walter J. CERTL Reduces C16 Ceramide, Amyloid-β Levels, and Inflammation in a Model of Alzheimer’s Disease Alzheimer’s Res. Ther. 2021 13 1 21 10.1186/s13195-021-00780-0 33597019 PMC7890977 · DOI
  157. [175]Adolf A. Rohrbeck A. Münster-Wandowski A. Johansson M. Kuhn H.-G. Kopp M.A. Brommer B. Schwab J.M. Just I. Ahnert-Hilger G. Release of Astroglial Vimentin by Extracellular Vesicles: Modulation of Binding and Internalization of C3 Transferase in Astrocytes and Neurons Glia 2019 67 703 717 10.1002/glia.23566 30485542 · DOI
  158. [176]Hira K. Ueno Y. Tanaka R. Miyamoto N. Yamashiro K. Inaba T. Urabe T. Okano H. Hattori N. Astrocyte-Derived Exosomes Treated with a Semaphorin 3A Inhibitor Enhance Stroke Recovery via Prostaglandin D2 Synthase Stroke 2018 49 2483 2494 10.1161/STROKEAHA.118.021272 30355116 · DOI
  159. [177]Pascua-Maestro R. González E. Lillo C. Ganfornina M.D. Falcón-Pérez J.M. Sanchez D. Extracellular Vesicles Secreted by Astroglial Cells Transport Apolipoprotein D to Neurons and Mediate Neuronal Survival Upon Oxidative Stress Front. Cell. Neurosci. 2019 12 526 10.3389/fncel.2018.00526 30687015 PMC6335244 · DOI
  160. [178]Wang G. Dinkins M. He Q. Zhu G. Poirier C. Campbell A. Mayer-Proschel M. Bieberich E. Astrocytes Secrete Exosomes Enriched with Proapoptotic Ceramide and Prostate Apoptosis Response 4 (PAR-4) J. Biol. Chem. 2012 287 21384 21395 10.1074/jbc.M112.340513 22532571 PMC3375560 · DOI
  161. [180]Croft C.L. Liu X. Ryu D.H. Ceballos-Diaz C. Tejeda G. Marrero M. Moran C. Cruz P.E. Ladd T. Moore B.D. Elucidating the Relationship between TGF-β Signaling and Alzheimer’s Disease Alzheimer’s Dement. 2020 16 e043570 10.1002/alz.043570 · DOI
  162. [181]Patel M.R. Weaver A.M. Astrocyte-Derived Small Extracellular Vesicles Promote Synapse Formation via Fibulin-2-Mediated TGF-β Signaling Cell Rep. 2021 34 108829 10.1016/j.celrep.2021.108829 33691102 PMC8002899 · DOI
  163. [182]Venturini A. Passalacqua M. Pelassa S. Pastorino F. Tedesco M. Cortese K. Gagliani M.C. Leo G. Maura G. Guidolin D. Exosomes from Astrocyte Processes: Signaling to Neurons Front. Pharmacol. 2019 10 1452 10.3389/fphar.2019.01452 31849688 PMC6901013 · DOI
  164. [183]Khan A.A. Xiao O.M. Banwait S. Jin K. Greenberg D.A. Neuroglobin Attenuates β-Amyloid Neurotoxicity in Vitro and Transgenic Alzheimer Phenotype in Vivo Proc. Natl. Acad. Sci. USA 2007 104 19114 19119 10.1073/pnas.0706167104 18025470 PMC2141917 · DOI
  165. [184]Bavisotto C.C. Scalia F. Gammazza A.M. Carlisi D. Bucchieri F. de Macario E.C. Macario A.J.L. Cappello F. Campanella C. Extracellular Vesicle-Mediated Cell–Cell Communication in the Nervous System: Focus on Neurological Diseases Int. J. Mol. Sci. 2019 20 434 10.3390/ijms20020434 30669512 PMC6359416 · DOI
  166. [185]Nafar F. Williams J.B. Mearow K.M. Astrocytes Release HspB1 in Response to Amyloid-β Exposure in Vitro J. Alzheimer’s Dis. 2015 49 251 263 10.3233/JAD-150317 26444769 · DOI
  167. [186]Chen S.Y. Lin M.C. Tsai J.S. He P.L. Luo W.T. Herschman H. Li H.J. EP4 Antagonist-Elicited Extracellular Vesicles from Mesenchymal Stem Cells Rescue Cognition/Learning Deficiencies by Restoring Brain Cellular Functions Stem Cells Transl. Med. 2019 8 707 723 10.1002/sctm.18-0284 30891948 PMC6591556 · DOI
  168. [187]Guitart K. Loers G. Buck F. Bork U. Schachner M. Kleene R. Improvement of Neuronal Cell Survival by Astrocyte-Derived Exosomes under Hypoxic and Ischemic Conditions Depends on Prion Protein Glia 2016 64 896 910 10.1002/glia.22963 26992135 · DOI
  169. [188]Bhatia S. Kim W.S. Shepherd C.E. Halliday G.M. Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia J. Mol. Neurosci. 2019 67 125 132 10.1007/s12031-018-1217-9 30467822 PMC6344390 · DOI
  170. [189]Dassati S. Waldner A. Schweigreiter R. Apolipoprotein D Takes Center Stage in the Stress Response of the Aging and Degenerative Brain Neurobiol. Aging 2014 35 1632 1642 10.1016/j.neurobiolaging.2014.01.148 24612673 PMC3988949 · DOI · Paper page
  171. [190]Lee B.-C. Kim H.-S. Shin T.-H. Kang I. Lee J.Y. Kim J.-J. Kang H.K. Seo Y. Lee S. Yu K.-R. PGE2 Maintains Self-Renewal of Human Adult Stem Cells via EP2-Mediated Autocrine Signaling and Its Production Is Regulated by Cell-to-Cell Contact Sci. Rep. 2016 6 26298 10.1038/srep26298 27230257 PMC4882486 · DOI
  172. [191]Kim H. Shin T. Lee B. Yu K. Seo Y. Lee S. Seo M. Hong I. Choi S.W. Seo K. Human Umbilical Cord Blood Mesenchymal Stem Cells Reduce Colitis in Mice by Activating NOD2 Signaling to COX2 Gastroenterology 2013 145 1392 1403.e8 10.1053/j.gastro.2013.08.033 23973922 · DOI
  173. [192]Chang J.-K. Li C.-J. Wu S.-C. Yeh C.-H. Chen C.-H. Fu Y.-C. Wang G.-J. Ho M.-L. Effects of Anti-Inflammatory Drugs on Proliferation, Cytotoxicity and Osteogenesis in Bone Marrow Mesenchymal Stem Cells Biochem. Pharmacol. 2007 74 1371 1382 10.1016/j.bcp.2007.06.047 17714695 · DOI
  174. [193]Da Costa Dias B. Jovanovic K. Gonsalves D. Moodley K. Reusch U. Knackmuss S. Weinberg M.S. Little M. Weiss S.F.T. The 37kDa/67kDa Laminin Receptor Acts as a Receptor for Aβ42 Internalization Sci. Rep. 2014 4 5556 10.1038/srep05556 24990253 PMC4080222 · DOI
  175. [194]Zhou J. Liu B. Alzheimer’s Disease and Prion Protein Intractable Rare Dis. Res. 2013 2 35 10.5582/irdr.2013.v2.2.35 25343100 PMC4204584 · DOI
  176. [195]Li Z. Moniruzzaman M. Dastgheyb R.M. Yoo S.W. Wang M. Hao H. Liu J. Casaccia P. Nogueras-Ortiz C. Kapogiannis D. Astrocytes Deliver CK1 to Neurons via Extracellular Vesicles in Response to Inflammation Promoting the Translation and Amyloidogenic Processing of APP J. Extracell. Vesicles 2020 10 e12035 10.1002/jev2.12035 33408815 PMC7775567 · DOI
  177. [196]Sánchez-López E. Ettcheto M. Egea M.A. Espina M. Cano A. Calpena A.C. Camins A. Carmona N. Silva A.M. Souto E.B. Memantine Loaded PLGA PEGylated Nanoparticles for Alzheimer’s Disease: In Vitro and in Vivo Characterization J. Nanobiotechnol. 2018 16 1 16 10.1186/s12951-018-0356-z PMC5870370 29587747 · DOI
  178. [197]Gromnicova R. Davies H.A. Sreekanthreddy P. Romero I.A. Lund T. Roitt I.M. Phillips J.B. Male D.K. Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes in Vitro PLoS ONE 2013 8 81043 10.1371/journal.pone.0081043 PMC3855187 24339894 · DOI
  179. [198]Shui B. Tao D. Cheng J. Mei Y. Jaffrezic-Renault N. Guo Z. A Novel Electrochemical Aptamer-Antibody Sandwich Assay for the Detection of Tau-381 in Human Serum Analyst 2018 143 3549 3554 10.1039/C8AN00527C 30004544 · DOI
  180. [199]Elbassal E.A. Morris C. Kent T.W. Lantz R. Ojha B. Wojcikiewicz E.P. Du D. Gold Nanoparticles as a Probe for Amyloid-β Oligomer and Amyloid Formation J. Phys. Chem. C 2017 121 20007 20015 10.1021/acs.jpcc.7b05169 PMC5737797 29276551 · DOI
  181. [200]Sanati M. Khodagholi F. Aminyavari S. Ghasemi F. Gholami M. Kebriaeezadeh A. Sabzevari O. Hajipour M.J. Imani M. Mahmoudi M. Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer’s Disease in a Rat Animal Model: Involvement of STIM Proteins ACS Chem. Neurosci. 2019 10 2299 2309 10.1021/acschemneuro.8b00622 30933476 · DOI
  182. [201]Muller A.P. Ferreira G.K. Pires A.J. Silveira G.d. de Souza D.L. Brandolfi J.d. de Souza C.T. Paula M.M.S. Silveira P.C.L. Gold Nanoparticles Prevent Cognitive Deficits, Oxidative Stress and Inflammation in a Rat Model of Sporadic Dementia of Alzheimer’s Type Mater. Sci. Eng. C 2017 77 476 483 10.1016/j.msec.2017.03.283 28532055 · DOI

Cited by

Sorted by citations

Authors
Nassar, A., Kodi, T., Satarker, S., Chowdari Gurram, P., Upadhya, D., SM, F., Mudgal, J., & Nampoothiri, M.
Affiliations
  • Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India
  • Centre for Molecular Neurosciences, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India
  • Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India
Venue
Cells
Publisher
MDPI AG
Published
2022-12-17
Volume
11
Issue
24
Pages
4111
ISSN
2073-4409
Cited by
36
References
19
Language
en
Funders
  • Council of Scientific and Industrial Research (CSIR/08/602 (0007)/2019-EMR I)
  • Manipal Academy of Higher Education (CSIR/08/602 (0007)/2019-EMR I)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review